Prenetics Global (PRE)
(Delayed Data from NSDQ)
$4.87 USD
+0.30 (6.56%)
Updated Aug 29, 2024 03:59 PM ET
After-Market: $4.56 -0.31 (-6.37%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Income Statements
Fiscal Year end for Prenetics Global Limited falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 22 | 276 | 0 | NA | NA |
Cost Of Goods | 13 | 144 | 0 | NA | NA |
Gross Profit | 9 | 132 | 0 | NA | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 61 | 155 | 4 | 0 | 0 |
Income After Depreciation & Amortization | -52 | -23 | -4 | 0 | 0 |
Non-Operating Income | -5 | -160 | 1 | NA | NA |
Interest Expense | 0 | NA | 0 | NA | NA |
Pretax Income | -57 | -183 | -3 | NA | NA |
Income Taxes | 0 | 7 | 0 | NA | NA |
Minority Interest | -2 | 0 | 0 | NA | NA |
Investment Gains/Losses | 0 | NA | 0 | NA | NA |
Other Income/Charges | 0 | NA | 0 | NA | NA |
Income From Cont. Operations | -56 | -190 | -3 | NA | NA |
Extras & Discontinued Operations | -8 | 0 | 0 | NA | NA |
Net Income (GAAP) | -63 | -190 | -3 | NA | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -44 | -16 | -4 | 0 | 0 |
Depreciation & Amortization (Cash Flow) | 8 | 8 | 0 | NA | NA |
Income After Depreciation & Amortization | -52 | -23 | -4 | 0 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 11.25 | 5.07 | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | -2.52 | 7.80 | NA | NA | NA |
Diluted Net EPS (GAAP) | -5.58 | -37.48 | -1.50 | NA | NA |
Fiscal Year end for Prenetics Global Limited falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 6.41 | -6.52 | 4.87 | 5.70 |
Cost Of Goods | NA | 2.63 | -3.71 | 3.24 | 3.56 |
Gross Profit | NA | 3.78 | -2.81 | 1.62 | 2.14 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 12.94 | 11.21 | 15.30 | 14.30 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -9.16 | -14.02 | -13.68 | -12.16 |
Non-Operating Income | NA | -0.15 | -3.15 | 0.94 | -3.62 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -9.31 | -17.17 | -12.74 | -15.78 |
Income Taxes | NA | -0.29 | -0.01 | -0.01 | -0.25 |
Minority Interest | NA | -0.48 | -0.57 | -0.51 | -0.40 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -9.02 | -17.16 | -12.73 | -15.54 |
Extras & Discontinued Operations | NA | -0.03 | -0.35 | -1.35 | -6.67 |
Net Income (GAAP) | NA | -8.57 | -16.95 | -13.57 | -21.81 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 12.22 | 12.12 | 176.15 | 10.60 |
Diluted EPS Before Non-Recurring Items | NA | -0.38 | -0.52 | -0.06 | -0.15 |
Diluted Net EPS (GAAP) | NA | -0.70 | -2.35 | -0.08 | -2.10 |